<DOC>
	<DOC>NCT00395629</DOC>
	<brief_summary>Brief Summary: This study was designed to explore a safe dose and characterize the preliminary safety and efficacy of ICL670 in adult patients with previously documented history of homozygous C282Y.</brief_summary>
	<brief_title>Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis</brief_title>
	<detailed_description />
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Hemochromatosis</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<criteria>Age 18 years of age or older Male or female patients homozygous for the C282Y mutation. Iron overload as documented by serum ferritin and transferrin saturation No known allergy or contraindication to the administration of deferasirox Ability to comply with all studyrelated procedures, medications, and evaluations Effective use of birth control measures. Iron overload not due to hereditary hemochromatosis Males with hemoglobin &lt;13 mg/dL, females with hemoglobin &lt;12 mg/dL Desferal treatment within 1 month of the screening visit Patients currently or previously treated with deferiprone or deferasirox Significant medical condition interfering with the ability to partake in this study Presence of a surgical or medical condition that might significantly alter the absorption, distribution, metabolism or excretion of any study drug Clinical evidence of Active Hepatitis B or C Positive HIV serology Pregnant or breast feeding patients Patients treated with systemic investigational drug within 4 weeks prior or with topical investigational drug within 7 days prior to the screening visit Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Deferasirox</keyword>
	<keyword>ICL670A</keyword>
	<keyword>Iron chelators</keyword>
	<keyword>Deferiprone</keyword>
	<keyword>Transfusional Hemochromatosis</keyword>
</DOC>